In vivo and in vitro studies have demonstrated that NO can activate NOTCH1 signaling, and loss of function mutations in NOTCH1 are associated with CAVD in humans (6, 15). Here, NOTCH1 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.